BridgeMD
Compares treatment options for Type 2 Diabetes
Official title Self-Myofascial Release Plus Exercise Versus Exercise Alone in Type 2 Diabetes
ClinicalTrials.gov ID: NCT07414914
What this study is testing
- What it's testing
- This randomized controlled trial aims to investigate the effects of adding self-myofascial release applied to the plantar fascia and gastrosoleus muscles to an exercise program on foot function, physical performance, and plantar fascia thickness in individuals with type 2 diabetes. Participants aged 30 to 65 years with controlled type 2 diabetes will be randomly allocated to either an exercise-only group or an exercise plus self-myofascial release group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 65, women only
You may be able to join if
- Individuals aged 30 to 65 years
- Diagnosed with type 2 diabetes mellitus for at least 1 year
- Controlled type 2 diabetes mellitus
- Able to ambulate independently without assistive devices
You likely can't join if
- Severe pes planus or pes cavus defined by the Foot Posture Index-6 (FPI-6) (score ≥ +10 or ≤ -5)
- History of plantar fasciitis
- Plantar fascia ulceration
- Peripheral neuropathy
- Diagnosed peripheral vascular disease
- History of lower extremity surgery or fracture during last year
See the full eligibility criteria
- Individuals aged 30 to 65 years
- Diagnosed with type 2 diabetes mellitus for at least 1 year
- Controlled type 2 diabetes mellitus
- Able to ambulate independently without assistive devices
- Severe pes planus or pes cavus defined by the Foot Posture Index-6 (FPI-6) (score ≥ +10 or ≤ -5)
- History of plantar fasciitis
- Plantar fascia ulceration
- Peripheral neuropathy
- Diagnosed peripheral vascular disease
- History of lower extremity surgery or fracture during last year
- Rheumatologic or connective tissue disorders affecting soft tissue properties
- Neurological or diagnosed cognitive disorders
- Pregnancy
- Other types of diabetes mellitus
- Obesity (BMI \> 30 kg/m²)
- Serious cardiopulmonary disorders, including heart failure, history of myocardial infarction, or severe chronic obstructive pulmonary disease or asthma
The study team makes the final eligibility decision.
Where it's taking place
- Izmir, İzmir, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Izmir, İzmir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.